Mediastinal lymphadenopathy in COVID-19: A review of literature

Pahnwat Tonya Taweesedt1, Salim Surani2

  • 1Department of Medicine, Corpus Christi Medical Center, Corpus Christi, TX 78404, United States.

Insights

Mediastinal lymphadenopathy, or enlarged lymph nodes in the chest, is not a typical finding in COVID-19 patients. This review summarizes literature on this association, highlighting the need for further research into its significance.

Area of Science:

  • Infectious Diseases
  • Radiology
  • Pulmonology

Background:

  • Novel coronavirus disease 2019 (COVID-19) is a global pandemic causing significant morbidity and mortality.
  • While pulmonary manifestations are common, COVID-19 can affect multiple organ systems, including the gastrointestinal, cardiac, and neurological systems.
  • Chest imaging typically reveals bilateral lung involvement with ground-glass opacities and consolidation.

Purpose of the Study:

  • To review and summarize existing literature on mediastinal lymphadenopathy in patients with COVID-19 infection.
  • To investigate the suggested or observed association between COVID-19 and enlarged mediastinal lymph nodes.
  • To highlight the need for further research to understand the clinical significance of this finding.

Main Methods:

  • Literature review and summary of studies investigating mediastinal lymphadenopathy in COVID-19 patients.
  • Analysis of reported cases and imaging findings related to mediastinal lymph node enlargement in the context of COVID-19.
  • Synthesis of current understanding regarding the prevalence and potential causes of mediastinal lymphadenopathy in COVID-19.

Main Results:

  • Mediastinal lymphadenopathy is not considered a typical finding on chest computed tomography (CT) in COVID-19 patients.
  • Literature suggests or investigates the presence of mediastinal lymph node enlargement in some COVID-19 cases.
  • The etiology of mediastinal lymphadenopathy in COVID-19 can be infectious or non-infectious, and it is often associated with other conditions like malignancy, sarcoidosis, and heart failure.

Conclusions:

  • The presence of mediastinal lymphadenopathy in COVID-19 patients requires further investigation.
  • Additional research is needed to better characterize the importance and implications of mediastinal lymphadenopathy in the context of COVID-19 infection.
  • Understanding this association may contribute to improved diagnostic and prognostic approaches for COVID-19.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
71
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
7.6K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
185
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
13.1K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
90